Federal contractor · DURHAM, NC

HEALTH DECISIONS, INC.

HEALTH DECISIONS, INC. received $2.8M in federal contract obligations in FY2026, on 5 awards (−9.2% vs FY2025). Since FY2017: $52.9M. Its largest customer was National Institutes of Health ($2.8M).

Obligations · FY2026
$2.8M
New awards
5
Sole-source
0.0%
Single offer
0.0%
UEI
CMKQYLSLNJG1
Small business
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 5.7MFY2017
  2. 5.8MFY2018
  3. 4.5MFY2019
  4. 1.7MFY2020
  5. 8.6MFY2021
  6. 6.5MFY2022
  7. 6.6MFY2023
  8. 7.6MFY2024
  9. 3.1MFY2025
  10. 2.8MFY2026

Top buying agencies

Obligations in FY2026.

  1. National Institutes of Health$2.8M100%
    5 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

  1. Research & development$2.8M100%

Where the work was performed

  1. Durham County, NC$1.6M56%
  2. Wake County, NC$1.2M44%

Integrity signals

Shares of the year's obligations, next to the country's.

  • Low competition0.0%
    US 39% · $0
  • Sole-source awards0.0%
    US 30% · $0
  • Single-offer competitions0.0%
    US 8.7% · $0
  • Urgency justifications0.0%
    US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Largest awards

  1. TASK ORDER 2: STATUS DETERMINATION AND PRIORITIZATION OF PIPELINE PRODUCTS UNDERGOING CLINICAL TRIALS FOR MALE AND FEMALE CONTRACEPTION$2.5M
    National Institutes of Health· Wake County, NC· Research & development· Sep 24, 2019 – Sep 10, 2026· 75N94019F00126
  2. STATISTICAL AND CLINICAL COORDINATING SERVICES FOR GROUPS C AND D OF CCN021 ENTITLED, "A STUDY TO EVALUATE THE PK AND PD OF IM OR SQ INJECTIONS OF LEVONORGESTREL BUTANOATE (LB) FOR FEMALE CONTRACEPTION"$2.3M
    National Institutes of Health· Wake County, NC· Research & development· May 24, 2023 – Apr 22, 2026· 75N94023F00002
  3. FINALIZATION, PROCUREMENT OF REGULATORY APPROVAL, AND COMPLETE START-UP ACTIVITIES FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL$2.2M
    National Institutes of Health· Wake County, NC· Research & development· Aug 25, 2023 – Jul 29, 2026· 75N94023F00003
  4. NICHD: R&D: SUPPORTING THE PHASE IIB CLINICAL TRIAL OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE (LB) FOR FEMALE CONTRACEPTION: NON-SEVERABLE$1.3M
    National Institutes of Health· Durham County, NC· Research & development· Jul 25, 2025 – Sep 17, 2026· 75N94025F00002
  5. NICHD: R&D: COORDINATION, MONITORING, FOLLOW-UP, EVALUATION, AND COMPLETION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION: NON-SEVERABLE$1.2M
    National Institutes of Health· Durham County, NC· Research & development· Apr 30, 2025 – May 13, 2026· 75N94025F00001

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 1 market (agency × industry), FY2024–FY2026.

  1. UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON$13.1M+271% in FY2026
    GALVESTON, TX · 96% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services
  2. PUBLIC HEALTH INSTITUTE$14.5M+4.8% in FY2026
    OAKLAND, CA · 99% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services
  3. MICROBIOTIX, INC.$11.9M−33% in FY2026
    WORCESTER, MA · 89% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.